New extended BMD panel for staphylococci and enterococci at EDL

Published at 2019.03.26

EDL offers BMD according to ISO 20776-1 for clinical isolates (external page).

 

From March 2019, we offer an additional panel for staphylococci and enterococci. The panel contains the following antimicrobial agents: ceftaroline, dalbavancin, oritavancin, telavancin, vancomycin, erythromycin, clindamycin, linezolid and tedizolid.